News & Updates

Norovirus a growing threat that remains under-recognized

30 Jul 2024 by

The major route of transmission, clinical impact and challenges of human noroviruses are largely under-recognized by healthcare professionals, an expert suggests.

Norovirus a growing threat that remains under-recognized

30 Jul 2024

Double whammy: Depression and IBD increase hospital readmission, death

23 Jul 2024 by

Individuals with comorbid depression and inflammatory bowel disease (IBD) are at increased risks for hospital readmission and mortality at 30 days after readmission as shown in a retrospective observational study presented at CCC 2024.

Double whammy: Depression and IBD increase hospital readmission, death

23 Jul 2024

Pasien IBD tidak alami peningkatan risiko kanker

23 Jul 2024

Penelitian terbaru menunjukkan bahwa penyakit inflamasi usus besar tidak meningkatkan risiko kanker. Selain itu, pengobatan IBD dengan aminoglikosida dihubungkan dengan penurunan risiko kanker jenis tertentu.

Pasien IBD tidak alami peningkatan risiko kanker

23 Jul 2024

Legume intake reduces colorectal cancer risk

30 Jun 2024 by

Eating legumes may help avert the development of colorectal cancer, according to a study that has found an inverse association between legume consumption and colorectal cancer risk.

Legume intake reduces colorectal cancer risk

30 Jun 2024

Tobacco smoke exposure early in life ups paediatric IBD risk

03 Jun 2024 by

A Scandinavian population-based birth cohort study reveals that children who were exposed to tobacco smoke during their early childhood have an increased risk of developing inflammatory bowel disease (IBD) later in life.

Tobacco smoke exposure early in life ups paediatric IBD risk

03 Jun 2024

48-week data ASSERT odevixibat’s role in ALGS

29 May 2024 by

Pooled analysis of the ASSERT and ASSERT-EXT studies show sustained improvements in multiple parameters with odevixibat in individuals with Alagille syndrome (ALGS), thus reinforcing its role in the treatment of this multisystem genetic disorder.

48-week data ASSERT odevixibat’s role in ALGS

29 May 2024

Dupilumab sustains histological remission in children with EoE

29 May 2024 by

Treatment with higher-dose dupilumab results in sustained improvements in histologic and endoscopic measures of eosinophilic esophagitis (EoE) in children, regardless of prior use of swallowed topical corticosteroids (STCs), according to a subanalysis presented at ESPGHAN 2024.

Dupilumab sustains histological remission in children with EoE

29 May 2024

High-resolution anorectal manometry detects HD in children ≤2 years old

28 May 2024 by

High-resolution anorectal manometry (HR‐ARM) can be a noninvasive primary screening tool for Hirschsprung’s disease (HD), particularly in children ≤2 years old, as shown in a comprehensive retrospective analysis.

High-resolution anorectal manometry detects HD in children ≤2 years old

28 May 2024

Ustekinumab dose intensification effective at achieving remission in certain IBD patients

26 May 2024 by

Two-thirds of patients with IBD treated at an IBD centre in Singapore required dose intensification (DI) while on ustekinumab, with over one-third of them achieving disease remission at 1 year, as shown in a retrospective observational study

Ustekinumab dose intensification effective at achieving remission in certain IBD patients

26 May 2024

IBD patients undergoing colectomy at high risk of kidney complications

23 May 2024

The rates of acute kidney injury (AKI) and kidney failure appear to rise following colectomy, especially total colectomy or colectomy with a prolonged stroma, in patients with inflammatory bowel disease (IBD), according to a nationwide Swedish cohort study.

IBD patients undergoing colectomy at high risk of kidney complications

23 May 2024

News & Updates

Filter by Specialty:

Specialty:

Norovirus a growing threat that remains under-recognized

Norovirus a growing threat that remains under-recognized

Double whammy: Depression and IBD increase hospital readmission, death

Double whammy: Depression and IBD increase hospital readmission, death

Pasien IBD tidak alami peningkatan risiko kanker

Pasien IBD tidak alami peningkatan risiko kanker

Legume intake reduces colorectal cancer risk

Legume intake reduces colorectal cancer risk

Tobacco smoke exposure early in life ups paediatric IBD risk

Tobacco smoke exposure early in life ups paediatric IBD risk

48-week data ASSERT odevixibat’s role in ALGS

48-week data ASSERT odevixibat’s role in ALGS

Dupilumab sustains histological remission in children with EoE

Dupilumab sustains histological remission in children with EoE

High-resolution anorectal manometry detects HD in children ≤2 years old

High-resolution anorectal manometry detects HD in children ≤2 years old

Ustekinumab dose intensification effective at achieving remission in certain IBD patients

Ustekinumab dose intensification effective at achieving remission in certain IBD patients

IBD patients undergoing colectomy at high risk of kidney complications

IBD patients undergoing colectomy at high risk of kidney complications